Lipocine Inc (LPCN)
4.44
-0.36
(-7.50%)
USD |
NASDAQ |
Apr 24, 16:00
4.455
+0.02
(+0.34%)
After-Hours: 20:00
Lipocine Total Liabilities (Quarterly): 2.632M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.632M |
| September 30, 2023 | 2.271M |
| June 30, 2023 | 1.931M |
| March 31, 2023 | 2.062M |
| December 31, 2022 | 1.908M |
| September 30, 2022 | 1.775M |
| June 30, 2022 | 2.304M |
| March 31, 2022 | 5.194M |
| December 31, 2021 | 6.912M |
| September 30, 2021 | 7.578M |
| June 30, 2021 | 11.43M |
| March 31, 2021 | 8.186M |
| December 31, 2020 | 10.01M |
| September 30, 2020 | 10.24M |
| June 30, 2020 | 10.40M |
| March 31, 2020 | 14.44M |
| December 31, 2019 | 13.37M |
| September 30, 2019 | 9.837M |
| June 30, 2019 | 9.827M |
| March 31, 2019 | 10.44M |
| December 31, 2018 | 11.42M |
| September 30, 2018 | 10.92M |
| June 30, 2018 | 11.42M |
| March 31, 2018 | 15.01M |
| Date | Value |
|---|---|
| December 31, 2017 | 6.345M |
| September 30, 2017 | 2.484M |
| June 30, 2017 | 2.900M |
| March 31, 2017 | 2.345M |
| December 31, 2016 | 1.326M |
| September 30, 2016 | 1.572M |
| June 30, 2016 | 2.585M |
| March 31, 2016 | 2.994M |
| December 31, 2015 | 3.392M |
| September 30, 2015 | 2.179M |
| June 30, 2015 | 1.665M |
| March 31, 2015 | 1.337M |
| December 31, 2014 | 1.634M |
| September 30, 2014 | 2.057M |
| June 30, 2014 | 1.670M |
| March 31, 2014 | 1.50M |
| December 31, 2013 | 1.284M |
| September 30, 2013 | 1.628M |
| June 30, 2013 | 0.0176M |
| March 31, 2013 | 0.015M |
| December 31, 2012 | 0.0119M |
| September 30, 2012 | 0.007M |
| June 30, 2012 | 0.0041M |
| March 31, 2012 | 0.0074M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.775M
Minimum
Sep 2022
14.44M
Maximum
Mar 2020
6.964M
Average
7.578M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 51.91M |
| Eliem Therapeutics Inc | 2.87M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.00M |
| Shareholders Equity (Quarterly) | 20.37M |
| Current Ratio | 8.687 |